Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 24.91% is in line with its 5-year average of 26.23%, around the middle of its 5-year range (18.84%–29.55%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.02% below its 12-month average of 25.42%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
24.91%
DEBT TO ASSETS RATIO AVG TTM
25.42%
DEBT TO ASSETS RATIO AVG 3Y
25.82%
DEBT TO ASSETS RATIO AVG 5Y
26.23%
DEBT TO ASSETS RATIO AVG 10Y
21.94%
DEBT TO ASSETS RATIO AVG 15Y
18.68%
DEBT TO ASSETS RATIO AVG 20Y
17.65%
CURRENT VS TTM AVG
-2.02%
CURRENT VS 3Y AVG
-3.53%
CURRENT VS 5Y AVG
-5.02%
CURRENT VS 10Y AVG
+13.54%
CURRENT VS 15Y AVG
+33.37%
CURRENT VS 20Y AVG
+41.09%
SECTOR MEDIAN · HEALTHCARE
0.28%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+8796.10%
vs the sector median at left
Humana Inc.
Market Cap
$48.73B
Debt to Assets Ratio
24.91%
TTM Avg
25.42%
3Y Avg
25.82%
5Y Avg
26.23%
Market Cap
$49.56B
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.14B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.95B
Debt to Assets Ratio
0.42%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$41.64B
Debt to Assets Ratio
0.28%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$41.43B
Debt to Assets Ratio
0.32%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$56.49B
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humana Inc. (HUM) | $48.73B | 24.91% | 25.42% | 25.82% | 26.23% |
| Becton, Dickinson and Company (BDX)vs › | $49.56B | 0.33% | N/A | N/A | N/A |
| Edwards Lifesciences Corporation (EW)vs › | $50.14B | 0.05% | N/A | N/A | N/A |
| IQVIA Holdings Inc. (IQV)vs › | $43.18B | 0.54% | N/A | N/A | N/A |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.95B | 0.42% | N/A | N/A | N/A |
| Agilent Technologies, Inc. (A)vs › | $41.64B | 0.28% | N/A | N/A | N/A |
| IDEXX Laboratories, Inc. (IDXX)vs › | $41.43B | 0.32% | N/A | N/A | N/A |
| Moderna, Inc. (MRNA)vs › | $56.32B | 0.12% | N/A | N/A | N/A |
| Cardinal Health, Inc. (CAH)vs › | $56.49B | 0.17% | N/A | N/A | N/A |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $35.28B | 0.23% | N/A | N/A | N/A |
Debt/Assets
24.9%
Debt/Equity
0.74
Current Ratio
1.74
Interest Coverage
2.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 24.91% |
| 2026-03-31 | 25.31% |
| 2025-12-31 | 26.54% |
| 2025-09-30 | 25.36% |
| 2025-06-30 | 24.99% |
| 2025-03-31 | 26.13% |
| 2024-12-31 | 26.47% |
| 2024-09-30 | 26.04% |
| 2024-06-30 | 25.74% |
| 2024-03-31 | 26.38% |
| 2023-12-31 | 26.16% |
| 2023-09-30 | 20.98% |
| 2023-06-30 | 20.80% |
| 2023-03-31 | 21.20% |
| 2022-12-31 | 26.88% |
| 2022-09-30 | 20.87% |
| 2022-06-30 | 27.40% |
| 2022-03-31 | 28.02% |
| 2021-12-31 | 29.55% |
| 2021-09-30 | 27.05% |
| 2021-06-30 | 18.84% |
| 2021-03-31 | 19.42% |
| 2020-12-31 | 20.37% |
| 2020-09-30 | 20.23% |
| 2020-06-30 | 20.24% |
| 2020-03-31 | 22.97% |
| 2019-12-31 | 21.05% |
| 2019-09-30 | 22.30% |
| 2019-06-30 | 21.34% |
| 2019-03-31 | 23.08% |
| 2018-12-31 | 23.95% |
| 2018-09-30 | 18.81% |
| 2018-06-30 | 15.09% |
| 2018-03-31 | 15.45% |
| 2017-12-31 | 18.44% |
| 2017-09-30 | 14.96% |
| 2017-06-30 | 15.44% |
| 2017-03-31 | 16.56% |
| 2016-12-31 | 16.37% |
| 2016-09-30 | 13.89% |
| 2016-06-30 | 13.93% |
| 2016-03-31 | 14.08% |
| 2015-12-31 | 15.37% |
| 2015-09-30 | 15.73% |
| 2015-06-30 | 15.06% |
| 2015-03-31 | 14.92% |
| 2014-12-31 | 16.26% |
| 2014-09-30 | 15.72% |
| 2014-06-30 | 11.22% |
| 2014-03-31 | 11.51% |
| 2013-12-31 | 12.54% |
| 2013-09-30 | 12.45% |
| 2013-06-30 | 12.50% |
| 2013-03-31 | 12.43% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 10.07% |
| 2012-06-30 | 9.01% |
| 2012-03-31 | 9.25% |
| 2011-12-31 | 11.10% |
| 2011-09-30 | 9.85% |
| 2011-06-30 | 10.69% |
| 2011-03-31 | 11.18% |
| 2010-12-31 | 12.91% |
| 2010-09-30 | 11.67% |
| 2010-06-30 | 12.20% |
| 2010-03-31 | 12.57% |
| 2009-12-31 | 14.50% |
| 2009-09-30 | 13.24% |
| 2009-06-30 | 13.42% |
| 2009-03-31 | 16.12% |
| 2008-12-31 | 16.57% |
| 2008-09-30 | 15.33% |
| 2008-06-30 | 14.94% |
| 2008-03-31 | 14.83% |
| 2007-12-31 | 15.20% |
| 2007-09-30 | 12.81% |
| 2007-06-30 | 11.09% |
| 2007-03-31 | 12.70% |
| 2006-12-31 | 15.47% |
| 2006-09-30 | 12.57% |
| 2006-06-30 | 13.79% |
| 2006-03-31 | 13.53% |
| 2005-12-31 | 15.94% |
| 2005-09-30 | 12.85% |
| 2005-06-30 | 16.90% |
| 2005-03-31 | 17.53% |
| 2004-12-31 | 14.65% |
| 2004-09-30 | 13.80% |
| 2004-06-30 | 14.89% |
| 2004-03-31 | 16.25% |
| 2003-12-31 | 16.03% |
| 2003-09-30 | 24.15% |
| 2003-06-30 | 21.01% |
| 2003-03-31 | 21.49% |
| 2002-12-31 | 14.34% |
| 2002-09-30 | 16.76% |
